Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$52.16 - $64.19 $156,480 - $192,570
-3,000 Reduced 29.27%
7,250 $455,000
Q1 2023

Jun 01, 2023

SELL
$70.23 - $86.01 $14,046 - $17,202
-200 Reduced 1.91%
10,250 $740,000
Q1 2022

May 10, 2022

BUY
$66.02 - $79.71 $316,896 - $382,607
4,800 Added 84.96%
10,450 $830,000
Q3 2021

Oct 08, 2021

BUY
$68.67 - $84.02 $387,985 - $474,713
5,650 New
5,650 $389,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Searle & Co. Portfolio

Follow Searle & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.